Start
Entdecken
nav.journalClub
Trends
Mehr
Synapse
⌘+K
Synapse
Sprache
Deutsch
Deutsch
Charles F. Voliva | Synapse
CF
Charles F. Voliva
PI3K/AKT/mTOR signaling in cancer
Novartis (Switzerland)
Share
Follow
Claim This Profile
About
Research focus
PI3K/AKT/mTOR signaling in cancer
Impact
74 pubs · 2,371 cites · h-index 22
Affiliations
Novartis (Switzerland)
Sequoia Hospital
Bristol-Myers Squibb (United States)
See all
Publications